Anticoagulation for Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: The Drug and the Duration

Myeloproliferative neoplasms are a common cause of splanchnic vein thrombosis, which causes significant morbidity and mortality. Indefinite anticoagulation is the mainstay of therapy, and vitamin K antagonists (VKAs) are routinely used since hematologists have the most experience with this drug clas...

Full description

Bibliographic Details

Published in:	Hemato
Main Authors:	Wafik G. Sedhom, Brady Lee Stein
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Subjects:	splanchnic vein thrombosis myeloproliferative neoplasms JAK2 V617F mutation anticoagulation polycythemia vera
Online Access:	https://www.mdpi.com/2673-6357/2/2/15